A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro
Bartosz Laczek, Maj Schneider Thomsen, Jakob Körbelin, Annette Burkhart, Torben Moos · 2025
Read A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro by Bartosz Laczek, Maj Schneider Thomsen, Jakob Körbelin, Annette Burkhart, Torben Moos (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12817821.txt.
Description
Bartosz Laczek and co-authors design a gene therapy vector meant to release proteins on the brain side of the blood-brain barrier, in a 2025 study. That barrier blocks most protein drugs from reaching the brain. One workaround is to make the barrier cells themselves produce the protein, but the cells may release it into the blood instead of the brain.
The team used a virus that targets brain vessel cells and added a protein fragment meant to steer release toward the brain side. In mice, the supposedly specific promoter also hit neurons, which muddied measurement in the living brain. In a lab model of the barrier, though, the added fragment raised release across the brain-facing side, most clearly with a general promoter. The authors conclude the steering idea works in the dish, while cleaner targeting is needed before the approach can be judged in animals.
Catalog record
| CREATOR | Bartosz Laczek, Maj Schneider Thomsen, Jakob Körbelin, Annette Burkhart, Torben Moos |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |